Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A BOUCHER

Showing results (191-200 of 254) with videos related to

Pageof 26
Sort By:
Lancet (London, England)|July 7, 1999
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trialJ Durant, P Clevenbergh, P Halfon, et al.
Genomics|May 16, 2001
Characterization of the human Xq21.3/Yp11 homology block and conservation of organization in primatesC A Sargent, C A Boucher, P Blanco, et al.
The Journal of Infectious Diseases|August 1, 1997
Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivoM Nijhuis, R Schuurman, D de Jong, et al.
AIDS Research and Human Retroviruses|August 26, 1998
Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected personsS M Bruisten, P Reiss, A E Loeliger, et al.
European Journal of Nuclear Medicine|January 1, 1988
The effects of stress on left ventricular ejection fractionM C Kiess, J E Dimsdale, R H Moore, et al.
Journal of Clinical Laboratory Analysis|January 1, 1990
Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30C A Boucher, W J Krone, J Goudsmit, et al.
Blood|December 23, 1999
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)M D Hazenberg, J W Stuart, S A Otto, et al.
Archives of Internal Medicine|April 1, 1988
Left ventricular ejection fraction. Physician estimates compared with gated blood pool scan measurementsK A Eagle, T Quertermous, D E Singer, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individualsP Reiss, F de Wolf, C L Kuiken, et al.
European Journal of Nuclear Medicine|January 1, 1987
Biodistribution of tantalum-178: a short-lived radiopharmaceutical for blood pool imagingR A Wilson, S Y Kopiwoda, R J Callahan, et al.
Pageof 26

Showing results (191-200 of 254) with videos related to

Sort By:
Pageof 26
Lancet (London, England)|July 7, 1999
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trialJ Durant, P Clevenbergh, P Halfon, et al.
Genomics|May 16, 2001
Characterization of the human Xq21.3/Yp11 homology block and conservation of organization in primatesC A Sargent, C A Boucher, P Blanco, et al.
The Journal of Infectious Diseases|August 1, 1997
Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivoM Nijhuis, R Schuurman, D de Jong, et al.
AIDS Research and Human Retroviruses|August 26, 1998
Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected personsS M Bruisten, P Reiss, A E Loeliger, et al.
European Journal of Nuclear Medicine|January 1, 1988
The effects of stress on left ventricular ejection fractionM C Kiess, J E Dimsdale, R H Moore, et al.
Journal of Clinical Laboratory Analysis|January 1, 1990
Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30C A Boucher, W J Krone, J Goudsmit, et al.
Blood|December 23, 1999
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)M D Hazenberg, J W Stuart, S A Otto, et al.
Archives of Internal Medicine|April 1, 1988
Left ventricular ejection fraction. Physician estimates compared with gated blood pool scan measurementsK A Eagle, T Quertermous, D E Singer, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individualsP Reiss, F de Wolf, C L Kuiken, et al.
European Journal of Nuclear Medicine|January 1, 1987
Biodistribution of tantalum-178: a short-lived radiopharmaceutical for blood pool imagingR A Wilson, S Y Kopiwoda, R J Callahan, et al.
Pageof 26